Maternal exposure to di-2-ethylhexylphthalate and adverse delivery outcomes: A systematic review

Reproductive Toxicology

Volumn 65, Issue , 2016, Pages 76-86

  Yaghjyan, Lusine ^a   Ghita, Gabriela L ^a   Dumont Driscoll, Marilyn ^a   Yost, Richard A ^b   Chang, Su Hsin ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Department of Communication Sciences and Disorders   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Birthweight; Gestational age; Phthalate exposure; Preterm delivery

Indexed keywords

PHTHALIC ACID; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ADVERSE OUTCOME; ASIAN; BIRTH WEIGHT; CAUCASIAN; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HISPANIC; HUMAN; MATERNAL BLOOD; MATERNAL EXPOSURE; MECONIUM; PREGNANCY OUTCOME; PREMATURE LABOR; REVIEW; UMBILICAL CORD BLOOD; URINALYSIS; URINE LEVEL; POLLUTANT; PREGNANCY; PREMATURITY;

BIRTH WEIGHT; DIETHYLHEXYL PHTHALATE; ENVIRONMENTAL POLLUTANTS; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH;

EID: 84978886185     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2016.07.002     Document Type: Review

References (117)

1. [1] Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Hauser, R., Prins, G.S., Soto, A.M., et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 30 (2009), 293–342.
2. [2] Olujimi, O.O., Fatoki, O.S., Odendaal, J.P., Okonkwo, J.O., Endocrine disrupting chemicals (phenol and phthalates) in the South African environment: a need for more monitoring. Water SA 3 (2010), 671–682.
3. [3] Duty, S.M., Ackerman, R.M., Calafat, A.M., Hauser, R., Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ. Health Perspect. 113 (2005), 1530–1535.
4. [4] Kato, K., Silva, M.J., Needham, L.L., Calafat, A.M., Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. Anal. Chem. 77 (2005), 2985–2991.
5. [5] CDC. Center for Disease Control and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals (2009).
6. [6] Wittassek, M., Koch, H.M., Angerer, J., Bruning, T., Assessing exposure to phthalates—the human biomonitoring approach. Mol. Nutr. Food Res. 55 (2011), 7–31.
7. [7] Frederiksen, H., Skakkebaek, N.E., Andersson, A.-M., Metabolism of phthalates in humans. Mol. Nutr. Food Res. 51 (2007), 899–911.
8. [8] Koch, H.M., Preuss, R., Angerer, J., Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure—an update and latest results. Int. J. Androl. 29 (2006), 155–165 discussion 181-5.
9. [9] Albro, P.W., Corbett, J.T., Schroeder, J.L., Jordan, S., Matthews, H.B., Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ. Health Perspect. 45 (1982), 19–25.
10. [10] Albro, P.W., Lavenhar, S.R., Metabolism of di(2-ethylhexyl)phthalate. Drug Metab. Rev. 21 (1989), 13–34.
11. [11] Hauser, R., Calafat, A.M., Phthalates and human health. Occup. Environ. Med. 62 (2005), 806–818.
12. [12] Meeker, J.D., Sathyanarayana, S., Swan, S.H., Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos. Trans. R Soc. Lond. B Biol. Sci. 364 (2009), 2097–2113.
13. [13] Talsness, C.E., Andrade, A.J., Kuriyama, S.N., Taylor, J.A., vom Saal, F.S., Components of plastic: experimental studies in animals and relevance for human health. Philos. Trans. R Soc. Lond. B Biol. Sci. 364 (2009), 2079–2096.
14. [14] Lyche, J.L., Gutleb, A.C., Bergman, A., Eriksen, G.S., Murk, A.J., Ropstad, E., et al. Reproductive and developmental toxicity of phthalates. J. Toxicol. Environ. Health B Crit. Rev. 12 (2009), 225–249.
15. [15] Koch, H.M., Rossbach, B., Drexler, H., Angerer, J., Internal exposure of the general population to DEHP and other phthalates—determination of secondary and primary phthalate monoester metabolites in urine. Environ. Res. 93 (2003), 177–185.
16. [16] Johns, L.E., Cooper, G.S., Galizia, A., Meeker, J.D., Exposure assessment issues in epidemiology studies of phthalates. Environ. Int. 85 (2015), 27–39.
17. [17] Gray, L.E. Jr., Wilson, V.S., Stoker, T., Lambright, C., Furr, J., Noriega, N., et al. Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int. J. Androl. 29 (2006), 96–104 discussion 105-8.
18. [18] Gray, L.E., Ostby, J., Furr, J., Wolf, C.J., Lambright, C., Parks, L., et al. Effects of environmental antiandrogens on reproductive development in experimental animals. Hum. Reprod. Update 7 (2001), 248–264.
19. [19] Shehata, A., Mohamed, Z., El-Haleem, M., Samak, M., Effects of exposure to plasticizers di-(2-ethylhexyl) phthalate and trioctyltrimellitate on the histological structure of adult male albino rats' liver. J. Clin. Toxicol. 3 (2013), 169–178.
20. [20] Rusyn, I., Peters, J.M., Cunningham, M.L., Effects of DEHP in the liver: modes of action and species-specific differences. Crit. Rev. Toxicol. 36 (2006), 459–479.
21. [21] Wei, Z., Song, L., Wei, J., Chen, T., Chen, J., Lin, Y., et al. Maternal exposure to di-(2-ethylhexyl)phthalate alters kidney development through the renin-angiotensin system in offspring. Toxicol. Lett. 212 (2012), 212–221.
22. [22] Kluwe, W.M., Huff, J.E., Matthews, H.B., Irwin, R., Haseman, J.K., Comparative chronic toxicities and carcinogenic potentials of 2-ethylhexyl-containing compounds in rats and mice. Carcinogenesis 6 (1985), 1577–1583.
23. [23] Kluwe, W.M., McConnell, E.E., Huff, J.E., Haseman, J.K., Douglas, J.F., Hartwell, W.V., Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. Environ. Health Perspect. 45 (1982), 129–133.
24. [24] Ito, Y., Yamanoshita, O., Asaeda, N., Tagawa, Y., Lee, C.-H., Aoyama, T., et al. Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor α-independent pathway. J. Occup. Health 49 (2007), 172–182.
25. [25] Crocker, J.F., Safe, S.H., Acott, P., Effects of chronic phthalate exposure on the kidney. J. Toxicol. Environ. Health 23 (1988), 433–444.
26. [26] Colon, I., Caro, D., Bourdony, C.J., Rosario, O., Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ. Health Perspect. 108 (2000), 895–900.
27. [27] Buck Louis, G.M., Gray, L.E. Jr., Marcus, M., Ojeda, S.R., Pescovitz, O.H., Witchel, S.F., et al. Environmental factors and puberty timing: expert panel research needs. Pediatrics 121:Suppl. 3 (2008), S192–207.
28. [28] Cobellis, L., Latini, G., De Felice, C., Razzi, S., Paris, I., Ruggieri, F., et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum. Reprod. 18 (2003), 1512–1515.
29. [29] Reddy, B.S., Rozati, R., Reddy, B.V., Raman, N.V., Association of phthalate esters with endometriosis in Indian women. BJOG 113 (2006), 515–520.
30. [30] Duty, S.M., Silva, M.J., Barr, D.B., Brock, J.W., Ryan, L., Chen, Z., et al. Phthalate exposure and human semen parameters. Epidemiology 14 (2003), 269–277.
31. [31] Hauser, R., Meeker, J.D., Duty, S., Silva, M.J., Calafat, A.M., Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology 17 (2006), 682–691.
32. [32] Joensen, U.N., Frederiksen, H., Jensen, M.B., Lauritsen, M.P., Olesen, I.A., Lassen, T.H., et al. Phthalate excretion pattern and testicular function: a study of 881 healthy Danish men. Environ. Health Perspect. 120 (2012), 1397–1403.
33. [33] Swan, S.H., Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ. Res. 108 (2008), 177–184.
34. [34] Meeker, J.D., Hu, H., Cantonwine, D.E., Lamadrid-Figueroa, H., Calafat, A.M., Ettinger, A.S., et al. Urinary phthalate metabolites in relation to preterm birth in Mexico city. Environ. Health Perspect. 117 (2009), 1587–1592.
35. [35] James-Todd, T., Stahlhut, R., Meeker, J.D., Powell, S.G., Hauser, R., Huang, T., et al. Urinary phthalate metabolite concentrations and diabetes among women in the national health and nutrition examination survey (NHANES) 2001–2008. Environ. Health Perspect. 120 (2012), 1307–1313.
36. [36] Stahlhut, R.W., van Wijngaarden, E., Dye, T.D., Cook, S., Swan, S.H., Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ. Health Perspect. 115 (2007), 876–882.
37. [37] Lind, P.M., Zethelius, B., Lind, L., Circulating levels of phthalate metabolites are associated with prevalent diabetes in the elderly. Diabetes Care 35 (2012), 1519–1524.
38. [38] Svensson, K., Hernandez-Ramirez, R.U., Burguete-Garcia, A., Cebrian, M.E., Calafat, A.M., Needham, L.L., et al. Phthalate exposure associated with self-reported diabetes among Mexican women. Environ. Res. 111 (2011), 792–796.
39. [39] Lopez-Carrillo, L., Hernandez-Ramirez, R.U., Calafat, A.M., Torres-Sanchez, L., Galvan-Portillo, M., Needham, L.L., et al. Exposure to phthalates and breast cancer risk in northern Mexico. Environ. Health Perspect. 118 (2010), 539–544.
40. [40] Yaghjyan, L., Sites, S., Ruan, Y., Chang, S.H., Associations of urinary phthalates with body mass index, waist circumference and serum lipids among females: National Health and Nutrition Examination Survey 1999–2004. Int. J. Obes. (Lond.), 2015, 1999–2004.
41. [41] Meeker, J., Ferguson, K., Phthalates human exposure and related health effects. Schecter, A., (eds.) Dioxins and Health, 3rd ed., 2012, John Wiley & Sons, Hoboken, NJ.
42. [42] Beyerlein, A., Lack, N., von Kries, R., Within-population average ranges compared with Institute of Medicine recommendations for gestational weight gain. Obstet. Gynecol. 116 (2010), 1111–1118.
43. [43] International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Di(2-ethylhexyl)phthalate, 77, Suppl. 7, 101. Lion, France (2013).
44. [44] Campioli, E., Batarseh, A., Li, J., Papadopoulos, V., The endocrine disruptor mono-(2-ethylhexyl)phthalate affects the differentiation of human liposarcoma cells (SW 872). PLoS One, 6, 2011, e28750.
45. [45] Dees, J.H., Gazouli, M., Papadopoulos, V., Effect of mono-ethylhexyl phthalate on MA-10 Leydig tumor cells. Reprod. Toxicol. 15 (2001), 171–187.
46. [46] Martinez-Arguelles, D.B., Papadopoulos, V., Mechanisms mediating environmental chemical-induced endocrine disruption in the adrenal gland. Front. Endocrinol., 6, 2015, 29.
47. [47] Huber, W.W., Grasl-Kraupp, B., Schulte-Hermann, R., Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit. Rev. Toxicol. 26 (1996), 365–481.
48. [48] Lapinskas, P.J., Brown, S., Leesnitzer, L.M., Blanchard, S., Swanson, C., Cattley, R.C., et al. Role of PPARα in mediating the effects of phthalates and metabolites in the liver. Toxicology 207 (2005), 149–163.
49. [49] Ferguson, K.K., McElrath, T.F., Chen, Y.H., Mukherjee, B., Meeker, J.D., Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: a repeated measures analysis. Environ. Health Perspect. 123 (2015), 210–216.
50. [50] Ajjan, R.A., Watson, P.F., Weetman, A.P., Cytokines and thyroid function. Adv. Neuroimmunol. 6 (1996), 359–386.
51. [51] Ferguson, K.K., Cantonwine, D.E., Rivera-Gonzalez, L.O., Loch-Caruso, R., Mukherjee, B., Anzalota Del Toro, L.V., et al. Urinary phthalate metabolite associations with biomarkers of inflammation and oxidative stress across pregnancy in Puerto Rico. Environ. Sci. Technol. 48 (2014), 7018–7025.
52. [52] Ferguson, K.K., Loch-Caruso, R., Meeker, J.D., Exploration of oxidative stress and inflammatory markers in relation to urinary phthalate metabolites: NHANES 1999–2006. Environ. Sci. Technol. 46 (2012), 477–485.
53. [53] Vetrano, A.M., Laskin, D.L., Archer, F., Syed, K., Gray, J.P., Laskin, J.D., et al. Inflammatory effects of phthalates in neonatal neutrophils. Pediatr. Res. 68 (2010), 134–139.
54. [54] Meeker, J.D., Calafat, A.M., Hauser, R., Di(2-ethylhexyl)phthalate metabolites may alter thyroid hormone levels in men. Environ. Health Perspect. 115 (2007), 1029–1034.
55. [55] Meeker, J.D., Ferguson, K.K., Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007–2008. Environ. Health Perspect. 119 (2011), 1396–1402.
56. [56] Boas, M., Main, K.M., Feldt-Rasmussen, U., Environmental chemicals and thyroid function: an update. Curr. Opin. Endocrinol. Diabetes Obes. 16 (2009), 385–391.
57. [57] Boas, M., Frederiksen, H., Feldt-Rasmussen, U., Skakkebaek, N.E., Hegedus, L., Hilsted, L., et al. Childhood exposure to phthalates: associations with thyroid function, insulin-like growth factor I, and growth. Environ. Health Perspect. 118 (2010), 1458–1464.
58. [58] Stagnaro-Green, A., Maternal thyroid disease and preterm delivery. J. Clin. Endocrinol. Metab. 94 (2009), 21–25.
59. [59] López, M., Figueras, F., Coll, O., Goncé, A., Hernández, S., Loncá, M., et al. Inflammatory markers related to microbial translocation among HIV-Infected pregnant women: a risk factor of preterm delivery. J. Infect. Dis. 213:3 (2016), 343–350.
60. [60] Ferguson, K.K., McElrath, T.F., Chen, Y.H., Loch-Caruso, R., Mukherjee, B., Meeker, J.D., Repeated measures of urinary oxidative stress biomarkers during pregnancy and preterm birth. Am. J. Obstet. Gynecol., 212, 2015 208 e1-8.
61. [61] Menon, R., Oxidative stress damage as a detrimental factor in preterm birth pathology. Front. Immunol., 5, 2014.
62. [62] Mattison, D.R., Damus, K., Fiore, E., Petrini, J., Alter, C., Preterm delivery: a public health perspective. Paediatr. Perinat. Epidemiol. 15:Suppl. 2 (2001), 7–16.
63. [63] McCormick, M.C., Litt, J.S., Smith, V.C., Zupancic, J.A., Prematurity an overview and public health implications. Annu. Rev. Public Health 32 (2011), 367–379.
64. [64] Parets, S.E., Bedient, C.E., Menon, R., Smith, A.K., Preterm birth and its long-term effects: methylation to mechanisms. Biology (Basel) 3 (2014), 498–513.
65. [65] Sutherland, M.R., Bertagnolli, M., Lukaszewski, M.A., Huyard, F., Yzydorczyk, C., Luu, T.M., et al. Preterm birth and hypertension risk: the oxidative stress paradigm. Hypertension 63 (2014), 12–18.
66. [66] Gunay, F., Alpay, H., Gokce, I., Bilgen, H., Is late-preterm birth a risk factor for hypertension in childhood. Eur. J. Pediatr. 173 (2014), 751–756.
67. [67] Leong, N.M., Mignone, L.I., Newcomb, P.A., Titus-Ernstoff, L., Baron, J.A., Trentham-Dietz, A., et al. Early life risk factors in cancer: the relation of birth weight to adult obesity. Int. J. Cancer 103 (2003), 789–791.
68. [68] Tamimi, R.M., Lagiou, P., Czene, K., Liu, J., Ekbom, A., Hsieh, C.C., et al. Birth weight, breast cancer susceptibility loci, and breast cancer risk. Cancer Causes Control 21 (2010), 689–696.
69. [69] Park, S.K., Kang, D., McGlynn, K.A., Garcia-Closas, M., Kim, Y., Yoo, K.Y., et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res., 10, 2008, R8.
70. [70] Xue, F., Michels, K.B., Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 8 (2007), 1088–1100.
71. [71] Snijder, C.A., Roeleveld, N., Te Velde, E., Steegers, E.A., Raat, H., Hofman, A., et al. Occupational exposure to chemicals and fetal growth: the Generation R Study. Hum. Reprod. 27 (2012), 910–920.
72. [72] Burdorf, A., Brand, T., Jaddoe, V.W., Hofman, A., Mackenbach, J.P., Steegers, E.A.P., The effects of work-related maternal risk factors on time to pregnancy, preterm birth and birth weight: the Generation R Study. Occup. Environ. Med. 68 (2011), 197–204.
73. [73] Ferguson, K.K., McElrath, T.F., Meeker, J.D., Environmental phthalate exposure and preterm birth. JAMA Pediatr. 168 (2014), 61–67.
74. [74] Ferguson, K.K., McElrath, T.F., Ko, Y.A., Mukherjee, B., Meeker, J.D., Variability in urinary phthalate metabolite levels across pregnancy and sensitive windows of exposure for the risk of preterm birth. Environ. Int. 70 (2014), 118–124.
75. [75] Huang, Y., Li, J., Garcia, J.M., Lin, H., Wang, Y., Yan, P., et al. Phthalate levels in cord blood are associated with preterm delivery and fetal growth parameters in Chinese women. PLoS One, 9, 2014, e87430.
76. [76] Adibi, J.J., Hauser, R., Williams, P.L., Whyatt, R.M., Calafat, A.M., Nelson, H., et al. Maternal urinary metabolites of di-(2-ethylhexyl)phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study. Am. J. Epidemiol. 169 (2009), 1015–1024.
77. [77] Suzuki, Y., Niwa, M., Yoshinaga, J., Mizumoto, Y., Serizawa, S., Shiraishi, H., Prenatal exposure to phthalate esters and PAHs and birth outcomes. Environ. Int. 36 (2010), 699–704.
78. [78] Huang, P.-C., Kuo, P.-L., Chou, Y.-Y., Lin, S.-J., Lee, C.-C., Association between prenatal exposure to phthalates and the health of newborns. Environ. Int. 35 (2009), 14–20.
79. [79] Latini, G., De Felice, C., Presta, G., Del Vecchio, A., Paris, I., Ruggieri, F., et al. In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ. Health Perspect. 111 (2003), 1783–1785.
80. [80] Lenters, V., Portengen, L., Rignell-Hydbom, A., Jonsson, B.A., Lindh, C.H., Piersma, A.H., et al. Prenatal phthalate, perfluoroalkyl acid, and organochlorine exposures and term birth weight in three birth cohorts: multi-pollutant models based on elastic net regression. Environ. Health Perspect. 124:3 (2016), 365–372.
81. [81] Zhang, Y., Lin, L., Cao, Y., Chen, B., Zheng, L., Ge, R.S., Phthalate levels and low birth weight: a nested case-control study of Chinese newborns. J. Pediatr. 155 (2009), 500–504.
82. [82] Zhao, Y., Shi, H.J., Xie, C.M., Chen, J., Laue, H., Zhang, Y.H., Prenatal phthalate exposure, infant growth, and global DNA methylation of human placenta. Environ. Mol. Mutagen. 56 (2015), 286–292.
83. [83] Steenland, K., Savitz, D., Future trends in environmental epidemiology. Steenland, K., Savitz, D.A., (eds.) Topic in Environmental Epidemiology, 1997, Oxford University Press, New York, 350–357.
84. [84] Philippat, C., Mortamais, M., Chevrier, C., Petit, C., Calafat, A.M., Ye, X., et al. Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ. Health Perspect. 120 (2012), 464–470.
85. [85] James-Todd, T.M., Meeker, J.D., Huang, T., Hauser, R., Seely, E.W., Ferguson, K.K., et al. Racial and ethnic variations in phthalate metabolite concentration changes across full-term pregnancies. J. Expo. Sci. Environ. Epidemiol., 2016, 10.1038/jes.2016.2.
86. [86] Zota, A., Woodruff, T., Abstracts of the 2011 Conference of the International Society of Environmental Epidemiology (ISEE). Abstract 979, Research Triangle Park, NC: Environmental Health Perspectives, 2011, 10.1289/ehp.isee2011.
87. [87] James-Todd, T.M., Chiu, Y.-H., Zota, A.R., Racial/ethnic disparities in environmental endocrine disrupting chemicals and women's reproductive health outcomes: epidemiological examples across the life course. Curr. Epidemiol. Rep. 3 (2016), 161–180.
88. [88] Yaghjyan, L., Carlsson, N.P., Ghita, G.L., Chang, S.-H., Associations of individual characteristics and lifestyle factors with metabolism of di-2-ethylhexyl phthalate in NHANES 2001–2012. Environ. Res. 149 (2016), 23–31.
89. [89] Burris, H.H., Collins, J.W., Wright, R.O., Racial/ethnic disparities in preterm birth: clues from environmental exposures. Curr. Opin. Pediatr. 23 (2011), 227–232.
90. [90] Bryant, A.S., Worjoloh, A., Caughey, A.B., Washington, A.E., Racial/ethnic disparities in obstetrical outcomes and care: prevalence and determinants. Am. J. Obstet. Gynecol. 202 (2010), 335–343.
91. [91] Huang, T., Saxena, A.R., Isganaitis, E., James-Todd, T., Gender and racial/ethnic differences in the associations of urinary phthalate metabolites with markers of diabetes risk: national health and nutrition examination survey 2001–2008. Environ. Health 13 (2014), 1–10.
92. [92] Genuis, S.J., Beesoon, S., Lobo, R.A., Birkholz, D., Human elimination of phthalate compounds: blood, urine, and sweat (BUS) study. Sci. World J., 2012, 2012, 615068.
93. [93] Calafat, A.M., Needham, L.L., Factors affecting the evaluation of biomonitoring data for human exposure assessment. Int. J. Androl. 31 (2008), 139–143.
94. [94] Hauser, R., Meeker, J.D., Park, S., Silva, M.J., Calafat, A.M., Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ. Health Perspect. 112 (2004), 1734–1740.
95. [95] Hoppin, J.A., Brock, J.W., Davis, B.J., Baird, D.D., Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ. Health Perspect. 110 (2002), 515–518.
96. [96] Braun, J.M., Smith, K.W., Williams, P.L., Calafat, A.M., Berry, K., Ehrlich, S., et al. Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ. Health Perspect. 120 (2012), 739–745.
97. [97] Adibi, J.J., Whyatt, R.M., Williams, P.L., Calafat, A.M., Camann, D., Herrick, R., et al. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ. Health Perspect. 116 (2008), 467–473.
98. [98] Davison, J.M., Dunlop, W., Ezimokhai, M., 24-Hour creatinine clearance during the third trimester of normal pregnancy. Br. J. Obstet. Gynaecol. 87 (1980), 106–109.
99. [99] van den Hooven, E.H., Pierik, F.H., de Kluizenaar, Y., Willemsen, S.P., Hofman, A., van Ratingen, S.W., et al. Air pollution exposure during pregnancy, ultrasound measures of fetal growth, and adverse birth outcomes: a prospective cohort study. Environ. Health Perspect. 120 (2012), 150–156.
100. [100] England, L.J., Kendrick, J.S., Wilson, H.G., Merritt, R.K., Gargiullo, P.M., Zahniser, S.C., Effects of smoking reduction during pregnancy on the birth weight of term infants. Am. J. Epidemiol. 154 (2001), 694–701.
101. [101] Godfrey, K.M., Barker, D.J., Fetal programming and adult health. Public Health Nutr. 4 (2001), 611–624.
102. [102] Langley-Evans, S.C., Developmental programming of health and disease. Proc. Nutr. Soc. 65 (2006), 97–105.
103. [103] Barker, D.J.P., The malnourished baby and infant: relationship with type 2 diabetes. Br. Med. Bull. 60 (2001), 69–88.
104. [104] Chiang, H.C., Kuo, Y.T., Shen, C.C., Lin, Y.H., Wang, S.L., Tsou, T.C., Mono(2-ethylhexyl)phthalate accumulation disturbs energy metabolism of fat cells. Arch. Toxicol. 90:3 (2016), 589–601.
105. [105] U.S. Department of Health and Human Services Public Health Service Agency for Toxic Substances and Disease Registry. Toxicological profile for Di(2-ethylhexyl)phthalate (2002).
106. [106] Mose, T., Knudsen, L.E., Hedegaard, M., Mortensen, G.K., Transplacental transfer of monomethyl phthalate and mono(2-ethylhexyl)phthalate in a human placenta perfusion system. Int. J. Toxicol. 26 (2007), 221–229.
107. [107] Ludwig, D.S., Currie, J., The association between pregnancy weight gain and birthweight: a within-family comparison. Lancet 376 (2010), 984–990.
108. [108] Frederick, I., Williams, M., Sales, A., Martin, D., Killien, M., Pre-pregnancy body mass index, gestational weight gain, and other maternal characteristics in relation to infant birth weight. Matern. Child Health J. 12 (2008), 557–567.
109. [109] Chiolero, A., Bovet, P., Paccaud, F., Association between maternal smoking and low birth weight in Switzerland: the EDEN study. Swiss Med. Wkly. 135 (2005), 525–530.
110. [110] Bernstein, I.M., Mongeon, J.A., Badger, G.J., Solomon, L., Heil, S.H., Higgins, S.T., Maternal smoking and its association with birth weight. Obstet. Gynecol. 106 (2005), 986–991.
111. [111] Mills, J.L., Graubard, B.I., Harley, E.E., Rhoads, G.G., Berendes, H.W., Maternal alcohol consumption and birth weight: how much drinking during pregnancy is safe. JAMA 252 (1984), 1875–1879.
112. [112] Nykjaer, C., Alwan, N.A., Greenwood, D.C., Simpson, N.A.B., Hay, A.W.M., White, K.L.M., et al. Maternal alcohol intake prior to and during pregnancy and risk of adverse birth outcomes: evidence from a British cohort. J. Epidemiol. Community Health 68 (2014), 542–549.
113. [113] Ray, J.G., Vermeulen, M.J., Shapiro, J.L., Kenshole, A.B., Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Diabetes Endocrine Pregnancy Outcome Study in Toronto. QJM 94 (2001), 347–356.
114. [114] Wolff, M.S., Engel, S.M., Berkowitz, G.S., Ye, X., Silva, M.J., Zhu, C., et al. Prenatal phenol and phthalate exposures and birth outcomes. Environ. Health Perspect. 116 (2008), 1092–1097.
115. [115] Whyatt, R.M., Adibi, J.J., Calafat, A.M., Camann, D.E., Rauh, V., Bhat, H.K., et al. Prenatal di(2-ethylhexyl)phthalate exposure and length of gestation among an inner-city cohort. Pediatrics 124 (2009), e1213–e1220.
116. [116] Weinberger, B., Vetrano, A.M., Archer, F.E., Marcella, S.W., Buckley, B., Wartenberg, D., et al. Effects of maternal exposure to phthalates and bisphenol A during pregnancy on gestational age. J. Matern. Fetal Neonatal Med. 27 (2014), 323–327.
117. [117] Casas, M., Valvi, D., Ballesteros-Gomez, A., Gascon, M., Fernandez, M.F., Garcia-Esteban, R., et al. Exposure to bisphenol a and phthalates during pregnancy and ultrasound measures of fetal growth in the INMA-sabadell cohort. Environ. Health Perspect. 124:4 (2016), 521–528.